Stanley Welle
- Role
- Director, Strategic Business Development at Personalis, Inc.
- Location
- Annapolis, MD, US
- LinkedIn followers
- 500 followers
About Stanley Welle
Business Leader with over 20+ years of successful commercial leadership, who works…
Experience
Director, Strategic Business Development
Jan 2020 — Present
Tumor Micro Environment (TME) is the next frontier of personalized medicine in oncology. Clinicians will need to look beyond a few hundred genes, in order to determine the right therapeutic options for their patients. Ultra-sensitive WES, tumor escape mechanisms, immune repertoire profiles, human leukocyte antigen (HLA) typing and loss of heterozygosity, neoantigen load, tumor mutational burden (TMB), microsatellite instability(MSI), oncoviral presence, gene expression signatures, and more will play into the decision making process for oncologist.
Education
Loyola University Maryland
B.S., Biology
The Cardinal Gibbons School
High School, College Preparatory
Skills
- Clinical Trials
- Medical Devices
- Pharmaceutical Industry
- Medicine
- Oncology
- Strategic Leadership
- Life Sciences
- Hardware Diagnostics
- Immunology
- Hematology
- Genomics
- Team Leadership
- Cancer
- Science
- Sales Management
- Healthcare
- Medical Diagnostics
- Hospitals
- Biotechnology
- Lifesciences
- Organizational Leadership
- Sales
- Molecular Diagnostics
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.